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Purpose: To present refractive outcomes from consecutive cases with the Alcon Wavelight® 
EX500 excimer laser using photorefractive keratectomy (PRK) in patients with high myopia.
Methods: A retrospective chart review of consecutive cases of high myopic eyes ($6.0 
Diopters [D]) undergoing PRK with the Alcon Wavelight EX500 excimer laser (Alcon Labo-
ratories, Fort Worth, TX, USA) was done. Moderately high myopic eyes (6.0 to ,8.0 D [6 D]) 
were compared with high myopic eyes (8.0 D or greater [8 D]). Outcomes measured included 
pre- and postoperative refractive error, uncorrected distance visual acuity (UDVA), corrected 
distance visual acuity, spherical equivalent correction (SEQ), haze incidence, and intraocular 
pressure (IOP).
Results: One hundred eighteen eyes of 63 patients were evaluated, with 59 eyes having 
12 months of follow-up. Thirty-one eyes of 19 patients had 8.0 D or more of myopia. Twelve-
month average LogMAR UDVA was −0.06 (20/17) for the 6 D group and −0.08 (20/16) for the 
8 D group. Average 12-month SEQ was −0.18 D and preoperatively was −7.52 D for the 6 D 
group and −0.09 and −9.02 in the 8 D group. Sixty-five eyes (86%) and 24 eyes (96%) had an 
SEQ within 0.50 D of emmetropia at 3 months in the 6 and 8 D groups, respectively. One eye 
had visually significant haze developed at 8 months. Three eyes had IOP elevation that resolved 
with addition of short-term topical IOP-lowering medication.
Conclusion: High myopic PRK with the Alcon Wavelight EX500 excimer laser yields excel-
lent refractive outcomes with a low incidence of complications.
Keywords: high myopia, PRK, wavefront-optimized, refractive surgery
Introduction
Photorefractive keratectomy (PRK) has increased in popularity over the last decade 
as it has been recognized that a wider range of corrections can be treated when com-
pared to LASIK.1 Still, many USA surgeons shy away from PRK, particularly in high 
myopia, because of concerns about slow recovery, inconvenience, risk of haze, more 
postoperative visits, and longer postoperative medication regimen. Despite slower 
recovery, PRK for high myopia has structural and mechanical advantages as compared 
to LASIK. Advantages include greater residual stromal bed and, therefore, less risk of 
ectasia and more reserve tissue for enhancement surgery if needed. Avoidance of early 
or late flap complications, although rare with femtosecond laser, is another desirable 
advantage of PRK. The newest generation 500 Hz high-frequency excimer laser, the 
Alcon Wavelight® EX500 (Alcon Laboratories, Fort Worth, TX, USA), has been shown 
to safely and effectively treat high myopia with LASIK.2 Before obtaining this laser, 
we would preferentially recommended LASIK or phakic intraocular lenses (PIOLs) to 
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highly myopic patients. Our excellent LASIK outcomes with 
the Wavelight EX500 caused us to reevaluate the success of 
high myopic PRK and offer this to appropriately screened 
patients. Herein, we compare outcomes with the Wavelight 
EX500 excimer laser for moderately high myopic eyes with 
6.0 D of myopia, but ,8.0 D of myopia (6 D) to a subset of 
eyes with myopia of 8.0 D or more (8 D).
Methods
The University of Utah Institutional Review Board approved 
the study and it was conducted in accordance with the tenets 
of the Declaration of Helsinki. All patients were provided 
with written informed consent. Eyes undergoing PRK with 
6.0 D or greater of myopic spherical equivalent (SEQ) 
were included in the study for distance correction. A subset 
analysis of eyes with 8.0 D or more of myopia was performed. 
Patients underwent a standard refractive screening examina-
tion with 1 surgeon (MDM). Patients with a history of prior 
refractive surgery, keratoconus, form-fruste keratoconus, 
and an ablation that would leave ,300 microns of residual 
stromal bed (RSB) were excluded.
Corneal epithelium was gently debrided after exposure 
to ethanol 20% in balanced salt solution for 35–40 seconds 
placed in an 8.0 mm well. Laser ablation was performed 
using the wavefront-optimized Alcon Allegretto Wavelight 
EX500 excimer laser according to the surgeon-optimized 
nomogram.3 Mitomycin C 0.02% (MMC) was used in all 
eyes because laser ablation depth was .60 microns, with 
application time being from 12 to 20 seconds based on the 
surgeon’s preference. Average MMC application time was 
12.8±2.42 and 16.4±3.03 seconds in the 6 and the 8 D groups, 
respectively. Immediately after MMC, the ocular surface was 
rinsed with chilled saline for 30 seconds. One drop of pred-
nisolone acetate 1%, a topical fluoroquinolone, and a topical 
nonsteroidal anti-inflammatory drug were instilled and then 
a soft bandage contact lens was placed over the eye.
Postoperatively patients used prednisolone acetate 1% 
suspension in the operative eye, starting at a frequency of 
4 times per day for the first week, then 2 times per day for 
3 weeks, and subsequently switched to fluorometholone 0.1% 
suspension. Fluorometholone was used 3 times per day for 
1 month, then 2 times per day for 1 month, and then stopped.
The primary outcome measure was uncorrected dis-
tance visual acuity (UDVA). Secondary outcomes included 
intraocular pressure (IOP), corrected distance visual acuity 
(CDVA), manifest refraction SEQ, time of MMC application, 
and incidence and grade of postoperative corneal haze, based 
on the Fantes scale.4 Significant IOP elevation was defined 
as $10 mmHg above baseline, or any IOP over 21 mmHg.
Standard statistics were calculated and used to describe 
the treatment groups in terms of all study variables including 
UDVA, CDVA, manifest refraction, presence or absence 
and degree of postoperative corneal haze, and incidence 
of other postoperative complications. A P-value of 0.05 or 
less was considered statistically significant. Data analysis 
was performed using Microsoft Excel (Microsoft Corp, 
Redmond, WA, USA).
Results
Sixty-three patients were included in the study. Thirty-
six patients (57%) were female and 27 (42%) were male. 
The average age was 32.7±7.76 (range 21–53). Six-month 
follow-up data were recorded on 83 eyes of 43 patients and 
12-month follow-up was obtained on 59 eyes of 32 patients. 
Demographic and preoperative parameters of patients in both 
the 6 and 8 D groups are compared in Table 1.
Average 6-month and 12-month UDVA values for both 
groups are shown in Figures 1 and 2, respectively. Average 
LogMAR UDVA at 6 months was −0.07 (20/17) in the 6 D 
group and −0.08 (20/16) in the 8 D group. UDVA was 20/20 
or better in 52 eyes (85%) in the 6 D group and 20 eyes (91%) 
in the 8 D group at 6 months (P=0.14). At 12 months, 40 eyes 
Table 1 Preoperative comparison of eyes in both groups
Eyes $6 D ,8 D (n=87) Eyes $8 D (n=31) P-value
age 32.7±7.76 (21–53) 32.2±6.64 (23–48) 0.720
Female/male 26 (52%)/24 (48%) 15 (79%)/4 (21%)
Mean logMar CDVa −0.07±0.07 (−0.125 to 0) −0.06±0.06 (−0.125 to 0) 0.471
CDVa (20/x) 17.0±2.46 (15 to 20) 17.4±2.49 (15 to 20) 0.420
spherical equivalent (D) −6.91±0.58 (−7.875 to −6) −9.02±0.73 (−10.5 to −8.00) ,0.001
sphere (D) −7.32±0.75 (−8.75 to −6.25) −9.51±0.96 (−11.75 to −8.25) ,0.001
Cylinder (D) 0.48±0.29 (0 to 3.00) 0.98±0.89 (0 to 2.50) 0.901
Note: Values represented as mean ± sD (range).
Abbreviations: CDVa, corrected distance visual acuity; D, diopters; logMar, logarithm of the minimum angle of resolution; $6 D ,8 D, more than or equal to 6 D but 
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high myopic photorefractive keratectomy outcomes with excimer laser
(93%) and 16 eyes (100%) had UDVA of 20/20 or better in 
the 6 and 8 D groups, respectively (P=0.36). Twelve-month 
average LogMAR UDVA was −0.06 (20/17) for the 6 D 
group and −0.08 (20/16) for the 8 D group.
Thirty-seven eyes (61%) had no change in CDVA after 
PRK at 6 months, whereas 19 eyes (31%) gained 1 line of 
CDVA in the 6 D group. Seven eyes (32%) had no change in 
CDVA and 14 eyes (64%) gained 1 line of CDVA 6 months 
after PRK in the 8 D group. Five eyes (8%) and 1 eye (5%) 
lost 1 line of CDVA in the 6 and 8 D groups, respectively 
(Figure 3). Figure 4 shows safety outcomes at 12 months. In 
the 8 D group, 6 eyes (38%) had no change in CDVA, 8 eyes 
(50%) gained 1 line, and 2 eyes (12%) lost 1 line of CDVA. 
In the 6 D group, 24 eyes (56%), 14 eyes (33%), and 5 eyes 
(12%) had no change in CDVA, gained 1 line, or lost 1 line 
of CDVA, respectively.
Postoperative spherical equivalent refraction (Figure 5) 
showed that 51 eyes (84%) and 20 eyes (91%) were within 
0.50 D of emmetropia at 6 months in the 6 and 8 D groups. 
Fifty-nine eyes (97%) and 22 eyes (100%) were within 1 D 
of emmetropia in the 6 and 8 D groups, respectively. At 
12 months, 37 eyes (86%) were within 0.5 D of emmetropia 
in the 6 D group, and 16 eyes (100%) in the 8 D group were 
within the same range (Figure 6).
Figure 7 shows the predictability of PRK corrections 
in both groups at 12 months. Three eyes (5%) were over-
corrected by 0.50 D. Ten eyes (17%) were undercorrected 
by 0.50 D, with 2 eyes (3%) undercorrected by −1.00 D. 
All eyes over- or undercorrected by 0.50 D or more were 
in the 6 D group. Fifty-two eyes (88%) had 0.25 D or less 
of astigmatism at 12 months (Figure 8). One eye (2%) 
had 1.25 D of astigmatism at 12 months. Figure 9 shows 
Figure 1 six-month postoperative UDVa versus preoperative CDVa.
Abbreviations: CDVa, corrected distance visual acuity; UDVa, uncorrected distance visual acuity; postop, postoperative; preop, preoperative.
Figure 2 Twelve-month postoperative UDVa versus preoperative CDVa.
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Figure 3 Percentage of eyes at 6 months postoperatively that lost or gained lines of snellen corrected distance visual acuity (CDVa).
Abbreviation: postop, postoperative.
Figure 4 Percentage of eyes at 12 months postoperatively that lost or gained lines of snellen CDVa.
Abbreviation: CDVa, corrected distance visual acuity; postop, postoperative.
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high myopic photorefractive keratectomy outcomes with excimer laser
refractive stability of corrections. Only 4% of eyes had 
a change in SEQ of 0.50 D or more from 3 to 12 months 
postoperatively.
Four eyes with ,8 D of myopia had visually insignificant 
trace to 1+ haze at the 1-month visit, with one of these eyes 
having persistent trace haze at 3 months with an UCVA of 
20/15. One eye developed late haze at 8 months with loss 
of 1 line of CDVA.
Three eyes of 2 patients had a significant IOP elevation 
during the first 3 postoperative months. IOP returned to 
baseline in both cases when the topical corticosteroid (fluo-
rometholone 0.1%) was stopped.
Discussion
Our analysis of 12-month outcomes of high myopic PRK with 
the Wavelight EX500 excimer laser shows the procedure to 
Figure 6 Twelve-month postoperative spherical equivalent refractive accuracy.
Abbreviation: postop, postoperative.
Figure 7 Twelve-month postoperative predictability of se with achieved se (y-axis) and attempted se (x-axis).
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Figure 8 Preoperative and 12-month postoperative refractive astigmatism with percentage of eyes (y-axis) versus refractive astigmatism (diopters [D]) on the x-axis.
Abbreviation: postop, postoperative; preop, preoperative.
Figure 9 stability of spherical equivalent refraction in diopters (D) at 1, 3, 6, and 12 months.
Abbreviation: postop, postoperative.
result in excellent UDVA and a low rate of complications. 
Kanellopoulos et al previously reported successful out-
comes with the same excimer laser in cases of high myopic 
LASIK.2 Our visual acuity outcomes are comparable to this 
study. With low rates of postoperative haze, we prefer PRK 
in cases of high myopia. Higher regression rates with high 
myopic corrections have been documented previously and 
PRK leaves more residual stromal bed in case an enhance-
ment surgery is indicated.5 PRK also negates concerns of 
LASIK flap complications and leaves more of the stronger 
anterior stroma intact. It has been suggested that the risk for 
ectasia may be lower with PRK.1 In cases of asymmetric 
inferior steepening with normal appearing posterior corneal 
elevation, we prefer PRK over LASIK.
The literature is mixed on whether LASIK or PRK 
results in more postoperative dry eye. Bower et al analyzed 
143 patients before and after LASIK and PRK.6 They found 
that 5% of PRK and 0.8% of LASIK eyes developed chronic 
dry eye 12 months after treatment. Alternatively, other studies 
have concluded that LASIK is associated with neurotrophic 
epitheliopathy7 and higher myopic ablations have been 
shown to result in higher rates of dry eye after LASIK.8 In 
comparison to PRK, LASIK has been shown to decrease tear 
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high myopic photorefractive keratectomy outcomes with excimer laser
in the arid western USA, we have observed a high incidence 
of dry eye in our screened refractive surgery candidates 
and more postoperative dry eye in our LASIK-treated eyes. 
Theoretically, this may be supported by the greater number 
of corneal nerves transected by a LASIK flap followed by 
ablation. If patients have preoperative dry eye signs and 
symptoms we tend to recommend PRK to help mitigate 
postoperative dry eye complications based on our personal 
experience. Others may be doing the same, and this may 
result in a bias confounding retrospective studies evaluating 
dry eye after LASIK and PRK.
Haze was uncommon in our study population with 5 eyes 
(4%) developing haze. Previous studies have reported the 
incidence of haze to be up to 20% after PRK, with visually 
significant haze in around 2% of eyes.10–12 Sia et al have 
shown that application of MMC following high myopic PRK 
leads to low rates of haze formation.11 Only 1 eye (0.8%) 
developed visually significant haze. The visually significant 
haze developed around 8 months after surgery. Late haze has 
been reported as a very rare complication, especially when 
using adjunctive MMC, which the affected eye received.13 
There is also a correlation with higher depth of ablation and 
haze development.14 Our PRK patients undergo a 3-month 
steroid taper and this has been successful in preventing haze 
formation.15 We believe that a slow steroid taper and mito-
mycin application are especially important in high myopes 
based on their increased risk for haze formation.
The group of eyes with 8 D or more of myopia had 
particularly good outcomes with 100% of the eyes being 
within 0.5 D of emmetropia 12 months after surgery. Our 
criteria for treating these highly myopic eyes was very strin-
gent and may have led to selecting eyes that were prone to 
better outcomes. Less ideal candidates were encouraged to 
consider PIOL as a vision correction option. The safety of 
conventional PRK in high myopia has been demonstrated 
previously.11 Wavefront-optimized treatments induce less 
higher-order aberrations and lead to better quality vision, 
but require more tissue per diopter of correction.16,17 The 
Wavelight EX500 is FDA-approved for higher myopic abla-
tions than any other wavefront excimer laser in the USA, 
allowing a higher range of corrections to be safely treated 
with this excimer technology. Study of long-term follow-up 
in this group is warranted as these eyes are known to have 
more myopic regression.
PRK has limitations. We try to avoid overflattening 
corneas, even with wavefront-optimized ablation patterns. 
Ectasia still may be a risk and higher-risk patients may be 
selected for PRK. Extreme vigilance for risk factors is of 
paramount importance in high myopes as there is little margin 
for error. Compliance with postoperative steroid regimens 
is important in prevention of haze. Corticosteroid eye drops 
cause elevated IOP in some patients. There is some unknown 
risk with MMC long-term. Patient expectations must be 
managed appropriately as the recovery after PRK is much 
longer than that of LASIK. We did not measure contrast 
sensitivity or perform formal testing of night vision side 
effects in this study population. Further study of subjective 
symptoms after high myopic PRK is warranted.
Our study is limited by its retrospective nature, small 
proportion of patients with 12-month outcomes, and lack of 
systematic symptom analysis. Prospective, long-term studies 
of high myopic PRK patients along with a study of post-PRK 
symptoms would be beneficial.
PRK is effective in reducing spectacle dependence in high 
myopes with low complication rates. Eyes with normal struc-
tural parameters can be safely treated with PRK while miti-
gating the risks of LASIK because of higher residual stromal 
bed per correction and more accurately correct astigmatism 
than currently available PIOLs. Appropriate candidates with 
6–11 D of myopia can be offered PRK as an excellent alter-
native to LASIK or PIOL for surgical vision correction.
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